Who
Adele M. Gulfo
Director
Company insider
Files Form 4 as: Director, Enpro; Director, Tyra Biosciences; Director, NewAmsterdam Pharma Company; Director, Myovant Sciences; Director, Bemis Co.
In numbers
- Trades disclosed
- 86
- Buys
- 1
- Sells
- 0
- Bought
- $4,981
- Sold
- $0
- Companies
- 5
- Companies where not an officer
- 5
- First trade
- 5 May 2016
- Last trade
- 16 Sep 2026
- Last filed
- 17 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Sep 2026filed 17 Sep 2026 | NPO Enprooption or derivative · Machinery | SEC FORM 4 Code A | $1,4365 at $287.16 | filing |
| 16 Sep 2026filed 17 Sep 2026 | NPO Enprooption or derivative · Machinery | SEC FORM 4 Code A | $1650.574 at $287.16 | filing |
| 16 Sep 2026filed 17 Sep 2026 | NPO Enprooption or derivative · Machinery | SEC FORM 4 Code A | $1,4365 at $287.16 | filing |
| 16 Sep 2026filed 17 Sep 2026 | NPO Enprooption or derivative · Machinery | SEC FORM 4 Code A | $1640.57 at $287.16 | filing |
| 17 Jun 2026filed 18 Jun 2026 | NPO Enprooption or derivative · Machinery | SEC FORM 4 Code A | $1,4544 at $363.62 | filing |
| 17 Jun 2026filed 18 Jun 2026 | NPO Enprooption or derivative · Machinery | SEC FORM 4 Code A | $1650.453 at $363.62 | filing |
| 17 Jun 2026filed 18 Jun 2026 | NPO Enprooption or derivative · Machinery | SEC FORM 4 Code A | $1,4544 at $363.62 | filing |
| 17 Jun 2026filed 18 Jun 2026 | NPO Enprooption or derivative · Machinery | SEC FORM 4 Code A | $1640.45 at $363.62 | filing |
| 28 May 2026filed 1 Jun 2026 | TYRA Tyra Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,160 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | TYRA Tyra Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,160 at $0.00 | filing |
| 18 Mar 2026filed 19 Mar 2026 | NPO Enprooption or derivative · Machinery | SEC FORM 4 Code A | $1,2535 at $250.59 | filing |
| 18 Mar 2026filed 19 Mar 2026 | NPO Enprooption or derivative · Machinery | SEC FORM 4 Code A | $1640.656 at $250.59 | filing |
| 18 Mar 2026filed 19 Mar 2026 | NPO Enprooption or derivative · Machinery | SEC FORM 4 Code A | $1,2535 at $250.59 | filing |
| 18 Mar 2026filed 19 Mar 2026 | NPO Enprooption or derivative · Machinery | SEC FORM 4 Code A | $1650.66 at $250.59 | filing |
| 12 Feb 2026filed 12 Feb 2026 | NPO EnproMachinery | SEC FORM 4 Code A | $140K567 at $246.91 | filing |
| 12 Feb 2026filed 12 Feb 2026 | NPO EnproMachinery | SEC FORM 4 Code A | $140K567 at $246.91 | filing |
| 7 Jan 2026filed 9 Jan 2026 | NAMS NewAmsterdam Pharma CompanyBiotechnology | SEC FORM 4 Code A | —3,400 | filing |
| 7 Jan 2026filed 9 Jan 2026 | NAMS NewAmsterdam Pharma Companyoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,300 at $0.00 | filing |
| 7 Jan 2026filed 9 Jan 2026 | NAMS NewAmsterdam Pharma Companyoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,300 at $0.00 | filing |
| 7 Jan 2026filed 9 Jan 2026 | NAMS NewAmsterdam Pharma CompanyBiotechnology | SEC FORM 4 Code A | —3,400 | filing |
News
No headline names them, or the companies they trade most, lately.